{"disease":{"id":"invasive-lobular-carcinoma","name":"invasive lobular carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01953588","title":"Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1473,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT04021069","title":"Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT07527468","title":"HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Hôpital du Valais","has_results":false},{"nct_id":"NCT02515110","title":"Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT07432633","title":"[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":71,"lead_sponsor_name":"Blue Earth Diagnostics","has_results":false},{"nct_id":"NCT01417286","title":"Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":true},{"nct_id":"NCT04252859","title":"[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"University of Utah","has_results":true},{"nct_id":"NCT01753908","title":"Broccoli Sprout Extract in Treating Patients With Breast Cancer","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT05919108","title":"Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Vanderbilt-Ingram Cancer Center","has_results":false},{"nct_id":"NCT07229417","title":"IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05837767","title":"A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue","phase":"NA","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06666439","title":"Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Julia Foldi","has_results":false},{"nct_id":"NCT04750473","title":"Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT06133647","title":"Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT06408168","title":"Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01706432","title":"Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}